NEW THERAPEUTIC APPROACH FOR TREATMENT AGE-RELATED MACULAR DEGENERATION (AMD)

V. Jakšiċ ,
V. Jakšiċ

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

L. Žorić ,
L. Žorić

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

M. Mirković ,
M. Mirković

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

D. Stamenković ,
D. Stamenković

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

D. Vukša ,
D. Vukša

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

N. Popović
N. Popović

Clinic for eye disease, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

Published: 01.01.2008.

Volume 36, Issue 1 (2008)

pp. 95-98;

https://doi.org/10.70949/pramed200801233J

Abstract

Exudative age-related macular degeneration is leading cause of irreversible vision loss in developed countries. Subfoveal localisation of choroidal neovascular membrane is the most difficult form for treatment. At the last three years, the new group of agens well-known as anti-VEGF agens was approved for treatment of exudative AMD. In that purpose, intravitreally administrated agens is recommended. Efficacy and safety of anti-VEGF agens were proved in short-time follow up period.

Keywords

References

1.
D.S. F, B.J. O ’Colmain, B. M. Prevalence of age-related macular disease in the United States. Arch Ophthalmol. 122:564–72.
2.
S. R, D. P, D. E. Global data on visual impairment in the year 2002. Bull World Health Organ. 82:844–51.
3.
R. K, B.E K. Linton K.I.: Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 99:933–43.
4.
S. M, P.J. R, C.A. P. Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 112:1035–47.
5.
Age-related Eye Disease Study (AREDS) Research Group: Potential risk health impact of Age-Related Eye Disease Study results: AREDS Report No.11. Arch Ophthalmol. 121:1621–4.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by